by admin | Jul 30, 2021 | Article
July 30, 2021 – BENLYSTA (belimumab) has been approved in Canada for the treatment of active lupus nephritis (LN) in adult patients.[i] BENLYSTA is available as an intravenous infusion and a subcutaneous injection. BENLYSTA has been available in Canada as...
by admin | Apr 19, 2021 | Article
Researchers Dr. Zahi Touma & Dr. Michelle Barraclough University Health Network A pilot study examining the relationship between cognitive dysfunction and cognitive fatigue in SLE using structural and functional MRIs of the brain and focusing on the underlying...
by admin | Apr 19, 2021 | Article
In July 2021, GSK received authorization under Health Canada’s Interim Order for Sotrovimab for Injection to treat COVID-19 in high-risk adults and adolescents. To read more please...
by admin | Apr 22, 2020 | Article
On the Friday April 24th edition of Arthritis at Home, Arthritis Consumer Experts interviewed Dr. Carter Thorne to get the latest information about patient access to hydroxychloroquine in Canada during the COVID-19...
by admin | Apr 19, 2020 | Article
Researchers Dr. Leslie Skeith & Dr. Megan Barber Mentor: Ann Clarke University of Calgary A prospective cohort study evaluating complement and platelet activation among lupus patients with antiphospholipid syndrome. Project Summary Problem: There is a high...
